Assessment of Lipid Profile in Non-Diabetic and Diabetic patients with Ischemic Heart Disease
Objective: The main aim of this study was to assess the lipid profile in non-diabetic and diabetic patients who were suffering from ischemic heart disease.
Place and Duration of Study: This study was completed in a duration of 6 months from June 2019 to November 2019 in medical units of General hospital Lahore.
Material and Methods: This cross sectional study consisted of 100 patients which were included in this study after informed consent. Patients of both genders were selected randomly and randomized sampling technique was used to collect the data. Diabetics and non-diabetics were classified into two groups. Among the non-diabetics and diabetics, patients who were having atherosclerotic disease were included in this study. Data was collected using carefully designed proforma and information regarding age, gender, clinical signs and symptoms and other relatable information was obtained. Necessary investigations like CBC and lipid profile were carried out. Hospital ethical committee approval was taken.
Results: A total of 100 patients were included in this study and then they were classified into three groups depending upon the health. 1st group was normal who had no disease, 2nd group had patients who had atherosclerosis and diabetes (DA) and 3rd group included patients who were non-diabetics and had atherosclerosis (NA). Despite the fact that patients were using statins to low cholesterol levels, their apolipoprotein Lp(a) levels were greater than 45mg/dl and a little difference was present in males and females. Average low density lipoproteins and total cholesterol levels were within normal value despite the fact that apolipoproteins were higher than 30mg/dl or 25mg/dl (recommended values).
Conclusion: It is concluded from our study that lipid profiles must be checked regularly in diabetic and non-diabetic patients who also have atherosclerosis to reduce the risk of cardiovascular diseases.
Oyama N, Gona P, Salton CJ, et al. Differential impact of age, sex, and hypertension on aortic atherosclerosis: the Framingham Heart Study. Arterioscler Thromb Vasc Biol. 2008;28:155–159.
American Diabetes Association (ADA) Standards of medical care in diabetes. Diabetes Care. 2007;30:4–41.
Pathak R, Pathak A. Study of life style habits on risk of type 2 diabetes. Int J Appl Basic Med Res. 2012;2:92–96.
Mooradian AD. Dyslipidemia in type 2 diabetes mellitus. Nat Clin Pract Endocrinol Metab. 2009;5:150–159.
Goff DC, Jr, Bertoni AG, Kramer H, et al. Dyslipidemia prevalence, treatment, and control in the Multi-Ethnic Study of Atherosclerosis (MESA): gender, ethnicity, and coronary artery calcium. Circulation. 2006;113:647–656.
Aekplakorn W, Taneepanichskul S, Kessomboon P, et al. Prevalence of dyslipidemia and management in the Thai population, national health examination survey IV, 2009. J Lipids. 2014:249584.
Cabrera M, Sanchez-Chaparro MA, Valdivielso P, et al. Prevalence of atherogenic dyslipidemia: association with risk factors and cardiovascular risk in Spanish working population. “ICARIA”study. Atherosclerosis. 2014;235:562–569.
Plana N, Ibarretxe D, Cabre A, et al. Prevalence of atherogenic dyslipidemia in primary care patients at moderate-very high risk of cardiovascular disease. Cardiovascular risk perception. Clin Investig Arterioscler. 2014 doi: 10.1016/j.arteri.2014.04.002. Published Online First: Jun 12.
Zhang L, Connelly JJ, Peppel K, et al. Agingrelated atherosclerosis is exacerbated by arterial expression of tumor necrosis factor receptor-1: evidence from mouse models and human association studies. Hum Mol
Stamler J, Dyer AR, Shekelle RB, et al. Relationship of baseline major risk factors to coronary and all-cause mortality, and to longevity: findings from long-term follow-up of Chicago cohorts. Cardiology. 1993;82:191–222.
Roeters van Lennep JE, Westerveld HT, Erkelens DW, et al. Risk factors for coronary heart disease: implications of gender. Cardiovasc Res. 2002;53:538–549.
- There are currently no refbacks.
This work is licensed under a Creative Commons Attribution 3.0 License.